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Abstract—Current prognostic risk scores in cardiac surgery 
are based on statistics and do not yet benefit from machine 
learning. Statistical predictors are not robust enough to 
correctly identify patients who would benefit from 
Transcatheter Aortic Valve Implantation (TAVI). This research 
aims to create a machine learning model to predict one-year 
mortality of a patient after TAVI. We adopt a modern gradient 
boosting on decision trees algorithm, specifically designed for 
categorical features. In combination with a recent technique for 
model interpretations, we developed a feature analysis and 
selection stage, enabling to identify the most important features 
for the prediction. We base our prediction model on the most 
relevant features, after interpreting and discussing the feature 
analysis results with clinical experts. We validated our model on 
270 TAVI cases, reaching an AUC of 0.83. Our approach 
outperforms several widespread prognostic risk scores, such as 
logistic EuroSCORE II, the STS risk score and the TAVI2-
score, which are broadly adopted by cardiologists worldwide. 
Keywords—TAVI, Aortic Valve disease, one-year mortality 
prediction, outcome prediction, machine learning 
I. INTRODUCTION 
Degenerative aortic valve stenosis (AS) is the most 
common valvular heart disease in the developed world. If left 
untreated the disease has a devastating course, rapidly causing 
death when symptoms develop. AS is caused by calcification 
of the aortic valve (AV). This could also lead to aortic valve 
regurgitation (AR) which also causes heart failure. The 
treatment for severe aortic valve disease consisted until 
recently of surgical aortic valve replacement (SAVR). 
However, in recent years TAVI has been developed and 
approved for use in severe to intermediate risk AV disease. 
Recently two randomized controlled trials have been 
published where use in low risk TAVI patients was non-
inferior compared to SAVR. Despite the increasing 
development of this technique, there still is a risk bound to it. 
The broad use of TAVI in the last years has shown high 
chance of successful outcomes. However, the frailest patients 
sometimes do not benefit and can have complications after the 
procedure. The cause for this partial success is still not known. 
So careful patient selection is paramount. Identifying those 
patients who have improvements or those who are at a higher 
risk after TAVI, is essential to maximize their survival, by 
providing an alternative treatment or therapy. Moreover, this 
would lead to an improvement in the use of the limited 
resources, which reduces the waiting lists. However, the 
identification of the patients that can have improvements from 
the TAVI procedure is a complex and still unsolved task 
because it is difficult to objectively quantify the improvements 
of a patient, in a daily routine. Furthermore, the patients that 
are at a higher risk, are often frail patients with several 
comorbidities and with an important medical history. 
Unfortunately, they can have severe complications, leading in 
the worst case to mortality, which further increases the 
motivation to find out why the identification was incorrect [1]. 
EuroSCORE II [2] and STS [3] risk scores are currently used 
for patient selection, but they were not developed for TAVI. 
Current predictors specifically designed for TAVI, such as 
TAVI2-SCORe [4] and Arnold SV et al. [5], do not offer 
optimal results. All these models are based on statistics. 
With this paper, we aim to develop with a supervised 
machine learning approach, a very specific model to predict 
one-year mortality for the TAVI use-case. In fact, mortality at 
one year has been identified by the medical experts as the life 
expectancy threshold, above which the TAVI procedure is 
enabled and worth to be performed. We aim to validate its 
performance on a dataset of 270 patients that have undergone 
TAVI in 2015 and 2016. 
We obtained promising prediction results and our work 
has the following contributions. Firstly, to the best of our 
knowledge, this is the first successful application of gradient 
boosting on decision trees for mortality risk prediction of 
TAVI. Secondly, by applying a state-of-the-art model 
explanation technique, we have created useful feature insight 
which allows the medical doctors and us to interpret the model 
and perform an optimal feature selection. Thirdly, we have 
validated our model on a retrospective clinical dataset and we 
have compared our prediction results with existing patient 
outcome predictors currently used in cardiac surgery. 
II. METHODS 
A. Dataset 
The anonymized dataset obtained from the Catharina 
Hospital consists of 270 TAVI procedures that were 
performed between January 2015 and December 2016. The 
average age of the patients, when TAVI procedure was 
performed, is 80.7 years, with a minimum age of 50.3 years 
and a maximum age of 94 years (standard deviation of 
6.2 years). In our population, 48% of the patients are female. 
The dataset was split into two categories and it has been 
classified a TAVI procedure as successful, when the patient 
survival was at least one year from the date of TAVI. 
Therefore, we split the patients into the following two classes: 
− Survived within the first year (240 patients), 
− Non-survived within the first year (30 patients, 50% of 
which did not survive within the first two months). 
The dataset consists of numerous numerical and categorical 
information data, which can be divided in five principal 
categories: medical history, clinical data, patient 
questionnaire, risk score and medication. 
 The retrospective study was approved by the local ethics 
committee and all enrolled patients signed informed consent. 
B. Initial processing of the dataset 
The overall processing steps of our data are depicted in 
Fig. 1. The initial processing described here is preceding the 
diagram and is based on discriminating between numerical 
and categorical features. Once each feature is defined, we 
analyze each individual feature in detail, by considering the 
mean, range and standard deviation of the numerical features, 
and the recurrence and instances of the categorical features. 
We have reorganized some initially given features and some 
have been introduced, resulting from combining original 
features. For example, we mention the Body Mass Index 
(BMI) computed from the Height and the Weight. An 
alternative feature processing has been applied for multiple 
answer questionnaires by using one-hot encoding. An 
additional approach has been reserved for the list of prescribed 
medicines. After analysis with the medical experts, we added 
and divided them into 28 pharmacological macro-categories, 
according to their class of medication therapy and to their 
mechanism of functioning. Concerning the dates included in 
the original dataset, that were describing when certain events 
occurred prior to TAVI, it was decided to define them relative 
to the TAVI procedure date. Finally, we computed the 
intermediate and final scores for the RAND-36 
questionnaire [6] according to the clinical guidelines. 
C. Gradient Boosting Algorithm 
Gradient Boosting on Decision Trees (GBDTs) is a 
supervised machine learning technique, which currently 
represents the state-of-the-art technique for models based on 
decision trees. Recently, a new categorical feature-specific 
model called CatBoost has been designed that outperforms  
several GBDTs algorithms [7], [8] such as: XGBoost (Chen 
and Guestrin, 2016) which does not have a dedicated pre-
processing for categorical features and LightGBM (Keet et al., 
2017) which is not advisable on small-scale data. 
The CatBoost model was used, since in clinical practice and 
consequently in this dataset, categorical features are common. 
Therefore, we can more easily exploit all the information 
provided in the dataset, leaving this innovative approach for 
pre-processing of the categorical and numerical features to the 
preliminary stage of CatBoost, see Fig. 1 at each input stage 
of each model. In fact, at the preliminary stage, CatBoost 
converts all the categorical features into numerical data by 
incorporating the recurrence of each instance, missing values 
(NaNs) are considered as an instance of the feature. Numerical 
features are then processed by aggregating different feature 
values in a histogram, which is specifically optimized for an 
efficient and fast memory access and elaboration. NaNs are 
processed as the minimum value of that feature to guarantee 
the split in the decision tree and to separate them more 
effectively from other numerical features. 
The second stage of CatBoost involves an algorithm that  
builds an ensemble model with an iterative approach. At the 
1𝑠𝑡  iteration, the algorithm learns from the dataset the first 
decision tree, to reduce the training error. At the 2𝑛𝑑 iteration, 
the algorithm learns from the dataset one more decision tree, 
to reduce the error made by the decision tree obtained at the 
1𝑠𝑡 iteration and the algorithm repeats this procedure for all 
succeeding  iterations until the iteration count is exceeded. 
This count is chosen to maximize the training of the model 
without overfitting the data and therefore reducing the 
generalization capabilities of the model. 
D. Feature Analysis and Selection 
The feature analysis stage is achieved by exploiting a new 
method that, with a local-level approach and its foundations in 
game theory, is able to provide interpretations and 
explanations of machine learning models, as shown in the first 
stage (left) of Fig. 1. 
We exploited the SHapley Additive exPlanations unified 
approach [9], [10], using Shapley values, which is a technique 
recently published and applied to compute the importance of 
each feature of a model. Once extracted, all the importance 
values for each feature, we compute the following average: 
 𝝋𝑚 =
∑ |𝜙𝑗,𝑚|
𝑛
𝑗=1
𝑛
 , (1) 
where 𝜙𝑗,𝑚   is the importance value of the feature 𝑚 for a 
patient 𝑗 on the total amount of 𝑛 patients.  We obtain then the 
estimate of the most important features in the decision making 
of the model. Consequently, we reorder them from most 
relevant downwards by reordering the feature vector list. 
The most important features were then discussed with the 
medical experts to find possible patterns and clinical 
explanations related to patient mortality. The validated 
relevant features which were confirmed by the clinical experts 
and that were found more discriminative in the decision 
process, have then been used to train the final model. 
E. Model training and resampling strategy 
At the feature analysis stage, we trained the model on a 
deep decision tree by including the entire dataset. We then 
Fig. 1 Diagram of the one-year prediction model for the TAVI procedure (Implementation with Scikit-learn [16]) 
 analyzed the model to evaluate the importance of each feature. 
While the temporary and the final model has been trained only 
with the most informative features by imposing a threshold, to 
discard all non-relevant features. We conducted also a visual 
inspection of the SHapley Additive exPlanations summary 
plot, as shown in Fig. 3, which proved to be useful when 
discussing the results with the medical experts. 
The training parameters of the final model have been chosen 
after performing a hyperparameter research, iterating different 
combinations of possible parameters and different levels of 
feature thresholds. We then identified which were more 
suitable for maximizing the F1 score and AUC metric, by 
performing k-fold cross-validation multiple times with 
different randomizations per iteration. The temporary models 
used for validation utilize the same parameters as the final one. 
The intrinsic imbalanced nature of the dataset, with a 1/8 
ratio led us to apply a random over-sampling strategy to the 
minority class (non-survived patients) until a balanced ratio 
with the majority class (survived patients) was reached. 
F. Validation and Evaluation 
Validation of the model has been performed with 5 times 
Leave-One-Out Cross-Validation (LOOCV), with a dedicated 
pipeline for each iteration. In fact, the previously discussed 
random over-sampling of the minority class is applied at every 
iteration, but only after each test sample is removed. 
Current state-of-the-art prognostic risk scores in cardiac 
surgery use the Area Under Curve (AUC) of the Receiver 
Operating Characteristic curve (ROC or C-statistic) as 
benchmark metric. However, this metric is not always the best 
choice, especially in the case of validation performed on a 
dataset with imbalanced classes. Therefore, we adopted other 
metrics such as sensitivity, specificity and F1 score. 
III. EXPERIMENTAL RESULTS 
A. Selected Features 
According to the results obtained with the SHapley 
Additive exPlanations and the related discussion of these 
results with the cardiologists, we identified the most relevant 
features for the prediction of one-year mortality for TAVI. 
The selected features are presented in alphabetical order 
and in order of importance, accordingly to the SHapley 
Additive exPlanations, in Table 1 and in Fig. 3, respectively. 
Table 1 Details of the most important features for the prediction 
Description Unit Abbreviation 
Mean value ± SD or Instances 
(sample size) 
Survived (240) Non-Survived (30) 
AV regurgitation - ECHOAR 
No (83) 
Mild (90) 
Moderate (19) 
Severe (13) 
No (12) 
Mild (6) 
Moderate (2) 
Severe (6) 
AV peak gradient mmHg AVPEAKGRAD 75.21 ± 26.70 (171) 64.87 ± 37.01 (21) 
Atrioventricular 
block 
- AVBPRE 
No (200) 
AV-block (34) 
AV-block III (2) 
No (18) 
AV-block (7) 
AV-block III (2) 
Beta blockers class 
of medicines 
- MEDBETAB 
Yes (26) 
No (214) 
Yes (11) 
No (19) 
Body Mass Index kg/m2 BMI 26.93 ± 4.21 (239) 26.17 ± 4.93 (30) 
Creatinine μmol/L CREAT 105.65 ± 50.14 (235) 122.43 ± 51.30 (30) 
General health score 0-100 QoLGENH 37.67 ± 14.51 (104) 22.14 ± 13.50 (7) 
Haematocrit % HCT 39 ± 5 (209) 36 ± 3 (30) 
Haemoglobin mmol/L HB 7.89 ± 1.03 (205) 7.38 ± 0.81 (29) 
Month of post-
procedure recovery 
- 
MONTH 
Jan, …, Dec 
(16,21,20,21,14,28, 
11,15,20,22,23,29) 
Jan, …, Dec 
(3,3,2,2,2,1, 
5,1,7,0,1,3) 
Previous devices 
- 
PRVDEVICE 
No (129) 
Yes (16) 
No (7) 
Yes (4) 
QRS duration msec TQRS 109.67 ± 27.75 (234) 122.81 ± 34.01 (26) 
Smoking status - SMOKING 
No (121) 
Former (45) 
Actual (14) 
No (8) 
Former (3) 
Actual (1) 
 
Fig. 2 ROC TAVI mortality prediction 
Other relevant features that have been discarded to maximize 
the results at the risk of a reduced generalization capability on 
other datasets are: risk scores related to bleeding with 
antiplatelet and NSAIDs, NYHA class, QTC interval, gender, 
GFR, recent Coronary Artery Bypass Grafting (CABG) 
interventions, previous myocardial infarction and further class 
of medicines (e.g. ACE inhibitor, ARBs and PPIs). 
We emphasize here that several factors are influencing the 
feature selection and the model training. Particularly, the order 
of the most important features can be highly influenced by the 
missing values. In fact, a certain feature can ascend or descend 
the list of the most important features proportionally to the 
amount of its missing values.  It must be said that missing 
values contain information as well, because they are a natural 
consequence of the clinical workflow, of the internal protocols 
adopted by each hospital and of the varying urgency that 
characterize each patient journey. However, by including all 
the features shown in Table 1, in the final model, we ensured 
an optimal overview of the patient, acquired with a multi-
disciplinary approach, which has shown promising 
generalization capability on this dataset. 
B. Evaluation of the model 
Current state-of-the-art prognostic risk score for the TAVI 
procedure is the TAVI2-SCORe [4] with an AUC of 0.72. 
EuroSCORE II and STS reached an AUC of 0.81 and 0.77, 
respectively. However, only 59 symptomatic patients with 
severe aortic stenosis were selected for this 30-day mortality 
study after the TAVI procedure [11]. 
We computed the ROC curve shown in Fig. 2 with an AUC of 
0.83. We reached an accuracy of 0.90 with a specificity of 0.97 
and sensitivity of 0.37. Finally, we computed an F1 score of 
0.45. All the evaluation metrics acquired during the validation 
of our prediction model are shown in Table 2 as value ± SD. 
As comparison, we re-performed the entire validation pipeline 
with other well-known machine learning algorithms. At this 
purpose, numerical values are scaled in the range ±1, replacing 
NaNs with 0 and One-Hot encoding is applied for categorical 
features, considering missing values as an instance apart. 
Table 2 Results of the TAVI mortality prediction model based on 
CatB = CatBoost and comparison with XGB = XGBoost [12], RFC = 
Random Forest Classifier [13], LR = Logistic Regression, SVM = Support 
Vector Machine [14] and GNB = Gaussian Naive Bayes 
Metrics 
CatB 
Hyper  
CatB XGB RFC LR SVM GNB 
Sensitivity 0.37 ± 0.06 0.33 ± 0.02 0.35 ± 0.04 0.14 ± 0.05 0.53 ± 0.01 0.49 ± 0.02 0.87 ± 0.00 
Specificity 0.97 ± 0.00 0.98 ± 0.00 0.91 ± 0.01 0.97 ± 0.01 0.72 ± 0.01 0.74 ± 0.01 0.20 ± 0.01 
Accuracy 0.90 ± 0.01 0.90 ± 0.00 0.85 ± 0.01 0.88 ± 0.01 0.70 ± 0.01 0.71 ± 0.01 0.27 ± 0.01 
F1 score 0.45 ± 0.06 0.44 ± 0.02 0.34 ± 0.03 0.21 ± 0.07 0.28 ± 0.01 0.27 ± 0.01 0.21 ± 0.00 
AUC-ROC 0.83 ± 0.00 0.83 ± 0.01 0.80 ± 0.00 0.79 ± 0.01 0.60 ± 0.01 0.58 ± 0.02 0.57 ± 0.01 
 Table 3 Performance comparison of different mortality predictors 
Model name 
Our 
approach 
TAVI2-
SCORe [4] 
Arnold SV 
et al. [5] 
EuroSCORE 
II [11] 
STS Risk 
Score [11] 
AUC 0.83 0.72 0.66 0.81 0.77 
Population 270 511 2830 59 59 
Mortality one-year one-year one-year 30-day 30-day 
As shown in Table 3, our prediction model outperforms 
current state-of-the-art predictors, suggesting that prediction 
models based on machine learning can offer better 
performances. This especially holds for those difficult clinical 
cases where statistical approaches are not able to perform 
outstanding results. It should be noted that one-year mortality 
is generally more challenging than 30-day mortality. 
IV. DISCUSSION 
A. Clinical considerations 
We evaluated each single feature with clinical experts, to 
provide explanations for each feature and the understanding 
of the possible interaction between all the different variables. 
With the goal of finding an answer to why certain features 
were considered more important than others in the decision 
making of the model, we infer the following conclusions. 
(a) Severe AV regurgitation is linked to heart failure and 
mortality, which is found also in our analysis. 
(b) A low AV peak gradient can be related to less severe aortic 
stenosis or to a dysfunctional left ventricle. High values are 
index of severe/critical aortic stenosis, that if untreated can 
lead to mortality for sudden cardiac death or heart failure. 
(c) Atrioventricular block is linked to higher syncope and 
mortality and needs to be treated with a pacemaker giving 
complications, which reduces survival. 
(d) Beta blocker class of medication are used to manage heart 
rhythms (atrial fibrillation or ventricular arrhythmia) and in 
case of heart failure. Both cases have an impact on survival. 
(e) Extreme values of Body Mass Index (BMI) are unhealthy 
factors, even though there is clinical relevance that slight 
overweight gives a better prognosis after surgery. 
(f) High blood creatinine concentration suggests that there is 
a kidney deficiency. 
(g) Very low values for the RAND-36 [15] general health 
score indicates that the life quality of the patient is very low. 
This can be related to other comorbidities that reduce survival. 
(h)(i) A low hematocrit and hemoglobin value may suggest 
anemia, which is linked to mortality. 
(j) The month on which each patient faces its post-procedure 
recovery has shown to be statistically related to survival. 
Certain cardiovascular complications are temperature related, 
while seasonal diseases also impact survival (comorbidities). 
(k) Previous devices such as pacemaker, are implanted when 
rhythm disturbances are present and may lead to long-term 
complications. ICD or CRT-D are implanted when the left 
ventricular function is very low or when the patient has deadly 
arrythmia. Both these factors lead to a lower life expectancy. 
(l) A high QRS duration is an index of a more diseased 
conduction system. This can lead to heart failure. 
(m) Smokers have a higher risk of any cardiovascular disease, 
again a proof of the fact that they have less chance to survive 
after an operation. 
V. CONCLUSION 
With this research, we aim to develop a predictive model for 
patient selection in cardiac surgery, specifically for the TAVI 
use-case, by exploiting a new state-of-the-art machine 
learning algorithm designed for categorical features. We have 
successfully identified the most important features to predict 
the one-year mortality and have developed a model based on 
the most relevant features. We validated our model on 
270 patients, obtaining promising results and outperforming 
current predictive models based on statistics. The model 
enables to identify the patients that would have no chance of 
surviving to the first year with an AUC on the ROC of 0.83 
and with a specificity and sensitivity of 0.97 and 0.37, 
respectively. Since our dataset was intrinsically imbalanced 
with a ratio of 1/8, we measured also the F1 score as evaluation 
metric for this model, which resulted in a value of 0.45. It is 
important to extend the validation of the model on other 
patient data, possibly by performing a validation on a larger 
dataset, as well as in an inter-center validation process. 
Summarizing, we successfully developed a new prediction 
model based on machine learning for the TAVI procedure, 
offering attractive and powerful results for the prediction of 
one-year mortality. This forms a solid basis for further 
technical investigation and clinical studies. 
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